Great West Life Assurance CO Nektar Therapeutics Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.64 - $3.15 $37,941 - $186,744	-59,284 Reduced 24.38%	183,836 $128,000
Q4 2022 Feb 10, 2023	BUY	$2.03 - $4.28 $6,388 - $13,469	3,147 Added 1.31%	243,120 $548,000
Q3 2022 Nov 01, 2022	BUY	$3.04 - $5.14 $158,046 - $267,223	51,989 Added 27.66%	239,973 $765,000
Q2 2022 Aug 12, 2022	BUY	$3.17 - $6.17 $595,909 - $1.16 Million	187,984 New	187,984 $713,000
Q2 2022 Aug 09, 2022	SELL	$3.17 - $6.17 $504,990 - $982,899	-159,303 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $789,225 - $1.34 Million	72,874 Added 84.32%	159,303 $2.15 Million
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $205,120 - $295,674	15,694 Added 22.19%	86,429 $1.56 Million
Q2 2021 Aug 11, 2021	BUY	$16.52 - $20.4 $2,775 - $3,427	168 Added 0.24%	70,735 $1.21 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $60,195 - $92,547	-3,635 Reduced 4.9%	70,567 $1.41 Million
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $172,145 - $207,731	-10,916 Reduced 12.82%	74,202 $1.26 Million
Q3 2020 Nov 17, 2020	BUY	$16.59 - $24.79 $1.41 Million - $2.11 Million	85,118 New	85,118 $1.41 Million
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $1.49 Million - $2.22 Million	-89,651 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$16.86 - $23.44 $27,431 - $38,136	-1,627 Reduced 1.78%	89,651 $2.08 Million
Q1 2020 May 14, 2020	BUY	$14.47 - $27.96 $94,329 - $182,271	6,519 Added 7.69%	91,278 $1.63 Million
Q4 2019 Feb 11, 2020	BUY	$15.87 - $23.12 $272,376 - $396,808	17,163 Added 25.39%	84,759 $1.83 Million
Q3 2019 Oct 25, 2019	SELL	$16.91 - $36.27 $2,265 - $4,860	-134 Reduced 0.2%	67,596 $1.23 Million
Q2 2019 Jul 31, 2019	SELL	$31.0 - $36.3 $55,769 - $65,303	-1,799 Reduced 2.59%	67,730 $0
Q1 2019 May 08, 2019	SELL	$31.58 - $46.35 $401,855 - $589,803	-12,725 Reduced 15.47%	69,529 $2.33 Million
Q4 2018 Feb 12, 2019	BUY	$30.43 - $56.65 $26,869 - $50,021	883 Added 1.09%	82,254 $2.56 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $93,663 - $138,075	2,016 Added 2.54%	81,371 $4.96 Million
Q2 2018 Aug 10, 2018	BUY	$46.25 - $104.45 $1.71 Million - $3.86 Million	36,943 Added 87.11%	79,355 $3.87 Million
Q1 2018 May 10, 2018	SELL	$57.4 - $108.44 $9.32 Million - $17.6 Million	-162,451 Reduced 79.3%	42,412 $4.51 Million
Q4 2017 Feb 09, 2018	SELL	$23.02 - $60.5 $189,040 - $496,826	-8,212 Reduced 3.85%	204,863 $12.2 Million
Q3 2017 Nov 09, 2017	BUY	$17.79 - $24.0 $3.79 Million - $5.11 Million	213,075	213,075 $5.05 Million

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$16.4 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$15.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$13.5 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$9.68 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.48 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $193M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account